— Know what they know.
Not Investment Advice

IRON NASDAQ

Disc Medicine, Inc.
1W: -6.5% 1M: -10.3% 3M: -0.6% YTD: -19.0% 1Y: +33.2% 3Y: +93.0% 5Y: -25.4%
$67.05
+2.98 (+4.65%)
 
Weekly Expected Move ±3.9%
$62 $64 $67 $69 $72
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 32 · $2.4B mcap · 29M float · 1.83% daily turnover · Short 81% of daily vol
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$2.4B
52W Range40-99.5
Volume571,171
Avg Volume530,611
Beta2.14
Dividend
Analyst Ratings
11 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOJohn D. Quisel
Employees94
SectorHealthcare
IndustryBiotechnology
IPO Date2020-08-12
321 Arsenal Street
Watertown, MA 02472
US
617 674 9274
About Disc Medicine, Inc.

Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.

Recent Insider Trades

NameTypeSharesPriceDate
Franchi Jean M. S-Sale 6,257 $69.24 2026-04-14
Savage William Jacob S-Sale 3,531 $66.12 2026-04-13
Savage William Jacob S-Sale 2,200 $66.81 2026-04-13
Franchi Jean M. S-Sale 400 $69.00 2026-04-13
Savage William Jacob S-Sale 4,392 $65.52 2026-03-02

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms